CTMX earnings
CytomX Therapeutics (CTMX) next earnings date and estimates, and its past reports: EPS against estimates, the surprise and revenue.
CTMX earnings history
| Quarter | Reported | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|---|
| Q2 2026 | Aug 6, 2026 | -0.09 | -0.08 | -16.76% | $1.42M |
| Q1 2026 | May 7, 2026 | -0.10 | -0.14 | 28.57% | $10.26M |
| Q4 2025 | Mar 16, 2026 | -0.22 | -0.08 | -175.00% | $663.00K |
| Q3 2025 | Nov 6, 2025 | -0.09 | -0.05 | -82.52% | $5.96M |
| Q2 2025 | Aug 7, 2025 | -0.00 | -0.06 | 98.11% | $18.66M |
| Q1 2025 | May 12, 2025 | 0.27 | 0.12 | 116.35% | $50.92M |
| Q4 2024 | Mar 6, 2025 | 0.22 | -0.23 | 195.65% | $38.09M |
| Q3 2024 | Nov 7, 2024 | 0.07 | -0.17 | 141.18% | $33.43M |
| Q2 2024 | Aug 8, 2024 | -0.08 | -0.14 | 42.86% | $25.11M |
| Q1 2024 | May 8, 2024 | 0.17 | -0.08 | 312.50% | $41.46M |
| Q4 2023 | Mar 11, 2024 | 0.01 | -0.03 | 133.33% | $26.61M |
| Q3 2023 | Nov 7, 2023 | 0.04 | -0.19 | 121.05% | $26.38M |
| Aug 8, 2023 | -0.02 | -0.20 | 90.00% | – | |
| May 9, 2023 | -0.05 | -0.11 | 54.88% | – | |
| Mar 27, 2023 | -0.43 | -0.24 | -79.17% | – | |
| Nov 8, 2022 | -0.35 | -0.31 | -12.90% | – | |
| Aug 4, 2022 | -0.37 | -0.36 | -2.78% | – | |
| May 5, 2022 | -0.37 | -0.36 | -2.78% | – | |
| Mar 1, 2022 | -0.40 | -0.28 | -42.86% | – | |
| Nov 4, 2021 | -0.35 | -0.31 | -12.90% | – |
- CTMX reports next on Nov 5, 2026, with EPS of -0.09 expected.
- CTMX beat EPS estimates in 22 of its last 44 reports.
Updated 2026-11-02 18:28 UTC